Silvant Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.1M | Sell |
25,811
-194
| -0.7% | -$22.4K | 0.11% | 110 |
|
|
2025
Q4 | $2.74M | Hold |
26,005
| – | – | 0.09% | 117 |
|
|
2025
Q3 | $2.18M | Sell |
26,005
-1,169
| -4% | -$96.3K | 0.08% | 123 |
|
|
2025
Q2 | $2.15M | Hold |
27,174
| – | – | 0.08% | 126 |
|
|
2025
Q1 | $2.44M | Hold |
27,174
| – | – | 0.11% | 111 |
|
|
2024
Q4 | $2.7M | Hold |
27,174
| – | – | 0.11% | 109 |
|
|
2024
Q3 | $3.11M | Sell |
27,174
-2,900
| -10% | -$345K | 0.14% | 101 |
|
|
2024
Q2 | $3.75M | Hold |
30,074
| – | – | 0.17% | 82 |
|
|
2024
Q1 | $3.99M | Hold |
30,074
| – | – | 0.19% | 76 |
|
|
2023
Q4 | $3.3M | Sell |
30,074
-64
| -0.2% | -$6.64K | 0.18% | 83 |
|
|
2023
Q3 | $3.12M | Hold |
30,138
| – | – | 0.19% | 76 |
|
|
2023
Q2 | $3.5M | Sell |
30,138
-12
| -0% | -$1.36K | 0.2% | 77 |
|
|
2023
Q1 | $3.23M | Hold |
30,150
| – | – | 0.21% | 87 |
|
|
2022
Q4 | $3.37M | Sell |
30,150
-69
| -0.2% | -$7.05K | 0.24% | 80 |
|
|
2022
Q3 | $2.62M | Sell |
30,219
-241
| -0.8% | -$21.5K | 0.18% | 93 |
|
|
2022
Q2 | $2.8M | Sell |
30,460
-400
| -1% | -$35.5K | 0.68% | 33 |
|
|
2022
Q1 | $2.55M | Sell |
30,860
-685
| -2% | -$54K | 0.49% | 51 |
|
|
2021
Q4 | $2.44M | Hold |
31,545
| – | – | 0.42% | 56 |
|
|
2021
Q3 | $2.39M | Sell |
31,545
-2,876
| -8% | -$219K | 0.43% | 61 |
|
|
2021
Q2 | $2.7M | Sell |
34,421
-2,603
| -7% | -$194K | 0.43% | 60 |
|
|
2021
Q1 | $2.75M | Hold |
37,024
| – | – | 0.47% | 57 |
|
|
2020
Q4 | $2.91M | Sell |
37,024
-205
| -0.6% | -$15.7K | 0.5% | 50 |
|
|
2020
Q3 | $2.97M | Sell |
37,229
-539
| -1% | -$42.2K | 0.56% | 43 |
|
|
2020
Q2 | $2.81M | Hold |
37,768
| – | – | 0.51% | 47 |
|
|
2020
Q1 | $2.79M | Hold |
37,768
| – | – | 0.61% | 46 |
|
|
2019
Q4 | $3.3M | Sell |
37,768
-235
| -0.6% | -$19.3K | 0.6% | 48 |
|
|
2019
Q3 | $3.07M | Sell |
38,003
-1,018
| -3% | -$81.6K | 0.61% | 48 |
|
|
2019
Q2 | $3.14M | Buy |
39,021
+2,174
| +6% | +$166K | 0.56% | 55 |
|
|
2019
Q1 | $2.94M | Buy |
36,847
+31,206
| +553% | +$2.33M | 0.53% | 56 |
|
|
2018
Q4 | $414K | Hold |
5,641
| – | – | 0.08% | 121 |
|
|
2018
Q3 | $384K | Hold |
5,641
| – | – | 0.05% | 146 |
|
|
2018
Q2 | $329K | Hold |
5,641
| – | – | 0.04% | 153 |
|
|
2018
Q1 | $296K | Buy |
+5,641
| New | +$305K | 0.04% | 165 |
|
Other funds holding MRK
VCM
VPM
Silvant Capital Management's MRK Position: Q1 2026 in Review
Silvant Capital Management reduced its Merck (MRK) stake by 0.75% in Q1 2026, selling an estimated $22.4K and leaving 25,811 shares worth $3.1M. The position accounts for 0.11% of the portfolio, ranked #110.
Silvant Capital Management first reported a position in MRK in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.99M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Silvant Capital Management held 25,811 shares of Merck worth $3.1M as of Q1 2026.
- Silvant Capital Management sold 194 Merck shares in Q1 2026, an estimated $22.4K.
- Merck made up 0.11% of Silvant Capital Management's portfolio in Q1 2026, its #110 holding.
- Silvant Capital Management first reported a position in Merck in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's Merck position peaked at $3.99M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.